Tracey Sacco
Corporate Officer/Principal bij SCHOLAR ROCK HOLDING CORPORATION
Vermogen: 875 302 $ op 31-03-2024
Profiel
Tracey Sacco is currently the Chief Commercial Officer at Scholar Rock Holding Corp.
Prior to this, she worked at Acceleron Pharma, Inc. as the SVP-Global Marketing & Alliance Management from 2012 to 2021.
She received her undergraduate degree from Boston College and her MBA from The Leonard N Stern School of Business.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 12-02-2024 | 49 285 ( 0.06% ) | 875 302 $ | 31-03-2024 |
Actieve functies van Tracey Sacco
| Bedrijven | Functie | Begin |
|---|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Corporate Officer/Principal | 06-02-2023 |
Eerdere bekende functies van Tracey Sacco
| Bedrijven | Functie | Einde |
|---|---|---|
| ACCELERON PHARMA INC. | Sales & Marketing | 01-09-2021 |
Opleiding van Tracey Sacco
| Boston College | Undergraduate Degree |
| The Leonard N Stern School of Business | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA. | Health Technology |
